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It has been suggested that human neutrophils exposed 
to preformed immune complexes or activated comple-
ment fragments generate o2- anions in extracellular 
medium. In vivo studies have revealed that oxygen in-
termediates produced by immune complex-activated 
neutrophils play an important role in subsequent tissue 
damage. Since it is difficult to obtain direct evidence 
that o2- is released into plasma in patients with systemic 
lupus erythematosus (SLE), we studied the capacities of 
their sera to stimulate 02 release by human neutrophils 
in vitro. Sera from patients with SLE significantly en-
hanced 02 generation by neutrophils compared to nor-
mal sera. The enhancing activity of serum in the induc-
tion of increased o2- generation correlated positively 
with the presence of serum immune complexes and neg-
atively with serum complement levels. The enhancing 
factors were analyzed by serum fractionation on Seph-
adex G-200 gel filtration, and were concluded to be 
immune complexes of intermediate size containing an 
activated complement fragment. 
02 anion is a highly reactive radical which is generated by 
neutrophils as a result of stimulation by soluble or particulate 
agents [1- 3]. 0 2 reacts spontaneously or enzymatically and 
forms potent oxygen intermediates (Ol) such as hydrogen per-
oxide (H20 2), hydroxyl radical (OH ·),and singlet oxygen C02 ) 
[4- 7]. OI provide the neutrophil with an important mechanism 
for bactericidal activity [8,9] . Although these reactive products 
are important in host defense mechanisms, they also constitute 
potential sources of injury. 0 2 has been implicated as having 
an important role in neutrophil-mediated cytotoxicity [10), 
_endothelial cell damage [11,12), and in the impairment ofT-
lymphocyte proliferation [13]. In addition, neutrophils are 
stimulated to liberate 0 2 into the extracellular medium by 
chemotactic factor [14] and aggregated immunog1obulins [15]. 
These processes may be relevant to the pathogenesis of tissue 
injury in systemic lupus erythematosus (SLE). In the present 
study, evidence was provided that neutrophils exposed to SLE 
sera showed enhanced 02 generation, and the factors corre-
sponding to 0 2 generating activity were analyzed. 
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Abbreviations: 
agg-lgG: aggregated lgG 
KRP: Krebs-Ringer phosphate-buffered solution 
01: oxygen intermediates 
PBS: phosphate-buffered saline 
PEG: polyethylene glycol 
SCZ: serum-coated zymosan 
SLE: systemic lupus erythematosus 
SOD: superoxide dismutase 
MATERIALS AND METHODS 
Isolation of Neutrophils 
Normal human neutrophils were obtained from heparinized venous 
blood by a slight modification of the method of Boyum [16] . Briefly, 
after removal of mononuclear cells from the blood by Ficoll-Hypaque 
gradient centrifugation, neutrophils were isolated by dextran sedimen-
tation . The neutrophils were resuspended in Krebs-Ringer phosphate-
buffered solution (KRP) at 4 X 106 ce lls/mi. The purity and viability 
of the cells obtained averaged 94- 96% and 95- 97%, respectively, as 
determined by Giemsa staining and the trypan blue dye exclusion test. 
Sera: 
Sera were obtained from 24 patients with SLE and were frozen at 
-so· c until use. Nine normal sera both freshly isolated and treated 
with repeated freezing and thawing were used. Diagnosis was made 
according to the preliminary criteria for SLE [17]. All patients whose 
sera were used satisfied these criteria. 
Determination. of Serum Complement 
and Immune Complex Levels 
The serum CH50 levels were determined by the method of Kent and 
F ife [18] . The serum concentration of C3, C4, and C5 was determined 
by the radial immunodiffusion gel technique employing commercial 
monospecific antibodies (C3, C5 plate-Hyland, C4 plate-MBL) . Serum 
immune complex levels were measured by a polyethylene glycol (PEG) 
precipitation method [19] . The amount of immune complex was ex-
pressed as the ratio of protein content in the pellet fraction to serum 
protein content. 
Preparation of Immune Reactants 
Aggregated lgG (agg-lgG) was prepared by heating 1% human lgG 
(Cohn fraction 11, Kabi AB) for 20 min at 63•C and used after 
centrifugation to remove large aggregates. Serum-coated zymosan 
(SCZ) was prepared as previously described [14] and was kept at -so· c 
unti l use. Native human lgG and untreated zymosan were also used for 
the experiments. 
Gel filtration . 
SLE or normal serum was fractionated by gel filtration on Sephadex 
G-200 (Pharmacia Fine Chemicals), using a column 1.5 X 80 em in 
size. The SLE serum used for gel filtration was from an active case 
whose CH50, C3, C4, and immune complex levels were 103, 58, 14, and 
10.9, respectively. Eluates were equilibrated with phosphate-buffered 
saline (PBS, pH 7.2, 0.01 M). The elution volume per tube was 1.68 ml, 
and each fraction containing protein, as shown by 280 nm optical 
density, was recorded on a Uvicord recorder (Hitachi). Three main 
fractions were pooled, concentrated, and the complement proteins were 
measured. These procedures were done at 4 ·c. 
Determination. of Oi Generation 
Duplicate reaction mixtures containing neutrophi ls (0.25 ml, 1 X 106 
cells) and 0.05 ml of serum or immune reactants were incubated for 10 
.min at 4•c . The serum or reactants were washed by centrifugation at 
170 g for 10 min, the cell pellets were resuspended in 1.8 ml of KRP, 
and cytochrome c solution was added at a final concentration of 75 !LM . 
These mixtures were incubated for 30 min at 37•c in a 5% C02 
incubator, and the reaction was terminated by placing the tubes in ice 
water. Cell-free supernatants after centrifugation were measured at 550 
nm in a Beckmann model 35 spectrophotometer. Five hundred micro-
grams of SCZ or untreated zymosan were used to activate the neutro-
phils in place of serum; 500 llg of agg-lgG or native lgG were used in 
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the same manner. In control experiments, neutrophils were incubated 
with buffer instead of with stimulating agents. Using ferricyanide and 
dithionite, the amount of cytochrome c that was reduced by neutrophi ls 
activated by stimulants and the amount of cytochrome c present were 
calculated as previously described using an absorbance coefficient of 
21.1 mM- 1cm-1 at 550 nm (20) . 
Both eluates and pooled eluates of SLE sera fractionated with 
Sephadex G-200 gel chromatography were used as stimulants in the 
same experiments. The effect of heat inactivation of these pooled serum 
fractions was also studied. 
RESULTS 
The cytochrome c reduction by stimulated neutrophils in 30 
min is shown in Table I. Cytochrome c reduction by SLE 
serum-stimulated neutrophils was 5.33 ± 2.48 nmol, whereas 
cytochrome c reduction by normal serum was 3.21 ± 0.83 nmol. 
The difference between them was significant (p < 0.05). A 
similar effect was noted with agg-lgG. Neither untreated zym-
osan nor native IgG significantly enhanced cytochrome c re-
duction by the neutrophils . The addition of superoxide dismu-
tase (SOD, Sigma) to these incubation mixtures completely 
inhibited cytochrome c reduction, suggesting that the reduction 
of cytochrome c is dependent on 0 2. The time course of Oi 
generation by neutrophils stimulated with SLE serum was 
similar to other 0 2- generating systems [14]. Repeatedly frozen 
and thawed normal serum showed increased generation of 0 2-, 
higher levels of immune complexes, and lower levels of comple-
ments as compared to freshly isolated normal serum (Table II). 
CH50 (p < 0.001), C3 (p < 0.01), and C4 (p < 0.01) levels were 
significantly lower and immune complexes (p < 0.01) were 
significantly higher in SLE sera used in these experiments as 
compared to repeated frozen and thawed normal sera (Table 
TABLE I. Cytochrome c reduction by neutrophils stimulated with 





SLE serum + SOD" 
Normal serum (freshly isolated) 




Serum-coated zymosan + SOD" 
Untreated zymosan 
















1.11 ± 0.09 
5.33 ± 2.4u 0.41 ± 0.07 b 
1.42 ± 0.45 
3.21 ± 0.8 
5.26 ± 0.65 
2.47 ± 0.58 
9.61 ± 0.57 
0.43 ± 0.05 
2.96 ± 0.11 
"SOD (superoxide dismutase) was added to the reaction mixture of 
cytochrome c and neutrophils after stimulation with serum or zymosan. 
b p < 0.05. 
II). Heat inactivation of SLE serum significantly suppressed 
Oi generating activity (Table III). The pooled eluates of the 
fractionated SLE serum were tested to characterize the factor 
which had the ability to induce 0 2 generation. Fraction 1, 
corresponding to the macromolecular proteins, showed an Oi 
generating activity which was significantly higher than that of 
fraction 2, which is mainly an IgG fraction (Table IV). The 
approximate m, was 480,000 in the former instance and 25,000-
12,400 in the latter (Fig 1). 02 generating activity in fraction 
3 was significantly reduced by heat inactivation, whereas that 
of fraction 1 was partially inhibited (Table IV) . Complement 
components C3, C4, and C5 were detected in fractions 1 and 3, 
but not in fraction 2. Serum immune complex levels were 
correlated with Oi generating activity in SLE sera (r = 0.45, p 
< 0.05; Fig 2). 0 2 generating activity in SLE serum was 
negatively correlated with serum CH50 (r = -0.516, p < 0.02; 
Fig 3) , C4 (r = 0.483, p < 0.05; Fig 4), and C3 (r = - 0.479, p < 
0.05; Fig 5). 
DISCUSSION 
Enhanced stimulation of 0 2 generation by normal human 
neutrophils was observed in sera of patients with SLE as 
compared with normal sera. 0 2 generating activity in SLE sera 
was negatively correlated with serum complement levels and 
positively correlated ~ith serum immune complex levels. 0 2 
generating activity in active SLE serum was found in both high 
and low m, fractions on Sephadex G-200 gel chromatography. 
The M, was estimated to be approximately 480,000 in the 
former case, and 25,000- 12,400 in the latter. Oi generating 
activity in the low M, fraction was heat labile, whereas the 
activity in the high M, fraction was partially inhibited by heat 
inactivation. The analysis of complement components in pooled 
SLE serum eluates differed from that of normal serum eluates, 
suggesting that the complement components detected in frac-
tion 1 of SLE serum on gel filtration are probably fixed to 
immune complexes, and those in fraction 3 are activated com-





Treated (56"C, 30 min) 
Normal: 
Untreated 






Values are expressed as mean± SD. 
reduction 
(nmol/30 
min/ 106 cells) 
6.64 ± 0.75" 
5.03 ± 0.86 
1.23 ± 0.92b 
0.28 ± 0.42 
a Untreated vs treated values were statistically significant at p < 
0.05. 
b Untreated vs treated values were statistically significant at p > 
0.05. 
TABLE II. Immunologic analysis of the serum used and the effects of freeze and thaw on the nature of normal serum 
Immunologic 










Values are expressed as mean± SD. 
77.46 ± 32.67 
20.88 ± 14.48 
5.67 ± 3.41 
69.79 ± 43.79 
31.42 ± 22.52 
1.80 ± 2.90 
Normal serum 
Freeze-thaw 
219.57 ± 27.39 
116.29 ± 15.21 
68.14 ± 19.46 
1.79 ± 0.59 
24.04 ± 19.23 
18.11 ± 5.70 
0.74 ± 0.61 
"Statistical significance of normal serum (freshly isolated) vs normal serum (freeze-thaw). 
b Immunoglobulins contents of 4% polyethylene glycol precipitation. 
Fresh 
p value• 
226.85 ± 31.58 > 0.05 
115.43 ± 18.54 > 0.05 
69.43 ± 19.10 > 0.05 
1.18 ± 0.38 > 0.05 
17.67 ± 17.40 > 0.05 
8.80 ± 2.39 < 0.01 
0.39 + 0.34 > 0.05 
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TABLE IV. Complement levels and effect oi heating on superoxide-generating activity in SLE serum subfractions fractionated by Sephadex G-200 
chromatography 
Subfractio n 
Complement levels (mg/dl) Cytochrome c reduction (nmol) 
p value 
C3 C4 C5 Untreated" Treated 
1 29 (0) 15 (0) 35 (0) 8.32 ± 0.24 7.74 ± 0.1 2 < 0.05 
2 0 (32) 0 (9) 0 (4.2) 6.87 ± 0.36 6.90 ± 0.43 > 0.05 
3 27 (20) 1.2 (0) 3 (0) 8.01 ± 0.10 6.92 ± 0.24 < 0.01 
The numbers in parentheses show t he complement levels of the pooled eluates of normal serum. 
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FIG 1. Distribution of superox ide-generating activity in SLE serum 
subfractions a fter Sephadex G-200 chromatography. A rrowheads show 
the elu t ion positions of marker proteins with M, indicated. 
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F IG 2. Relationship between immune complex levels and superox-
ide-generating activi ty in SLE serum ( r = 0.45 ; p < 0.05). 
plement products. Aggregated lgG and complement activated 
via the alternative complement pathway in SCZ were capable 
of releasing 0 2 from neutrophils, as shown in prev ious work 
[14]. 
These results suggest t hat immune compl~xes of intermediate 
size with bound complement components in SLE serum are 
capable of stimulating 0 2 production in neutrophils, and that 
immunoglobulins as well as complement components, which 
are the constit uents of immune complexes in SLE serum , can 
play an important role in neutrophil activat ion. Furthermore, 
t he findings suggest t hat activated complement fragments 
themselves a re t he source of neutrophil stimulation, alt hough 
c 
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FIG 3. Relationship between CH50 levels a nd superox ide-generat-
ing activity in SLE serum (r = -0.516; p < 0.02) . 
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FIG 4. Relationship between C4 levels and superoxide-generating 
activity in SLE serum ( r = -0.483; p < 0.05) . 
precise analysis of the complement components involved has 
not been carried out. 
It has been suggested t hat immune complexes can stimulate 
neutrophils to release lysosomal proteases which mediate tissue 
damage by direct hydrolysis of basement membranes and in -
directly by amplifying the in£1ammatory process via t he gen-
eration of t he chemotactic fragment C5a [21]. Recently other 
mechanisms have been proposed to explain t he pathogenic 
nature of immune complexes. It has been observed that neut ro-
phi ls incubated with immune complexes generate OI . [22). In 
vitro studies have revealed t hat 01 can mediate t he destruction 
of target cells [23-26). In vivo studies have demonstrated that 
01 generated by immune complex-stimulated neutrop hils play 
an important role in tissue damage [27,28]. It appears t hat 
production of 0 2 accentuates inflammatory cell infiltration, 
presumably by generation of chemotactic lipid in the plasma 
(29). 
Sept. 1983 SLE SERUM FACTORS ENHANCING 02 GENERATION BY NEUTROPHILS 215 
12 
~ ~ 10 0 Ill 
"tl M ~~ 8 



















FIG 5. Relationship between C3 levels and superoxide-generating 
activity in SLE serum (r = -0.479; p < 0.05). 
Thus, neutrophils exposed to immune compiexes could me-
diate tissue damage via the generation of cytotoxic 01. In the 
present studies, evidence has been provided that 0 2 is gener-
ated into extracellular fluid from neutrophils activated by im-
mune complexes and activated complement products in SLE 
sera. 
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